Body Composition Analysis in Cirrhotic Undergoing Paracentesis
NCT02022150 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2019-02-01
Summary
Ascites is a frequent complication of liver cirrhosis, initial treatment consists on diuretics intake, however, as the disease progresses this complication becomes more severe, consequently other therapeutic options are used.
Paracentesis is indicated when severe ascites is present and it should be accompanied by albumin infusion.
Nutritional status is generally affected in patients with liver cirrhosis, even more patients with severe ascites show decreased energy intake due to gastric compression.
Conditions
- Liver Cirrhosis
- Ascites
Interventions
- BEHAVIORAL
-
Body composition in paracentesis
Takin blood samples and bioelectrical impedance measurmeent, Neuropsychological tests evaluation
Sponsors & Collaborators
-
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
lead OTHER
Principal Investigators
-
Aldo Torre, M.D, M.Sc. · Instituto Nacional de Nutrición y Ciencias Médicas "Salvador Zubirán"
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2021-06-30
- Completion
- 2021-12-31
Countries
- Mexico
Study Locations
More Related Trials
-
Improving Performance of Paracentesis in Medical Residency Training
NCT01403987 ·Status: COMPLETED ·Phase: NA
-
Methods for Nutritional Assessment in Cirrhosis
NCT02926261 ·Status: UNKNOWN
-
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394 ·Status: SUSPENDED ·Phase: NA
-
Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory Ascites
NCT04406298 ·Status: UNKNOWN ·Phase: NA
-
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
NCT01288794 ·Status: COMPLETED ·Phase: PHASE4
-
Bioelectrical Impedance Vector Analysis in Cirrhotic Patients
NCT01603953 ·Status: COMPLETED
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
NCT06525623 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.
NCT04816240 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
NCT04679571 ·Status: UNKNOWN ·Phase: NA
-
The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis
NCT01777971 ·Status: WITHDRAWN
-
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
NCT00603200 ·Status: WITHDRAWN
-
High Dose Albumin in Refractory Ascites
NCT05867602 ·Status: RECRUITING ·Phase: PHASE2
-
Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver.
NCT06892535 ·Status: COMPLETED ·Phase: PHASE4
-
Midodrine and Albumin in Patients With Refractory Ascites
NCT04621617 ·Status: UNKNOWN ·Phase: PHASE3
-
TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis
NCT00222014 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.
NCT06245590 ·Status: UNKNOWN ·Phase: NA
-
Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics
NCT02818673 ·Status: UNKNOWN ·Phase: PHASE3
-
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
NCT03871894 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.
NCT04474262 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study
NCT05220891 ·Status: UNKNOWN
-
Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites
NCT02612519 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .
NCT03084185 ·Status: UNKNOWN
-
Metabolic Effects of Furosemide +HSS in Refractory Ascites
NCT02821377 ·Status: COMPLETED ·Phase: PHASE2
-
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
NCT05249374 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
NCT07072572 ·Status: COMPLETED ·Phase: PHASE3